GUIDED THERAPEUTICS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Guided Therapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Guided Therapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$709K, a 54.5% increase year-over-year.
  • Guided Therapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$2.17M, a 59.2% increase year-over-year.
  • Guided Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$3.49M, a 19.6% increase from 2022.
  • Guided Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$4.34M, a 110% decline from 2021.
  • Guided Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$2.07M, a 642% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2.17M -$709K +$848K +54.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$3.02M -$402K +$467K +53.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$3.49M -$386K +$1.42M +78.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$4.91M -$677K +$425K +38.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$5.33M -$1.56M -$631K -68.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$4.7M -$869K -$362K -71.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$4.34M -$1.81M -$1.22M -208% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$3.12M -$1.1M -$1.17M -1721% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.95M -$926K +$108K +10.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$2.06M -$507K +$10K +1.93% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$2.07M -$587K -$2.77M -127% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $700K $68K -$1.51M -95.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.21M -$1.03M +$5.73M +84.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$3.52M -$517K -$3.25M -119% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$279K $2.18M +$1.1M +102% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$1.38M $1.58M +$1.7M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$3.08M -$6.77M -$4.1M -154% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-18
Q1 2020 $1.02M $2.73M +$2.94M Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-08-18
Q4 2019 -$1.92M $1.08M +$3.82M Oct 1, 2019 Dec 31, 2019 10-K 2021-04-07
Q3 2019 -$5.74M -$126K +$620K +83.1% Jul 1, 2019 Sep 30, 2019 10-Q/A 2020-11-05
Q2 2019 -$6.36M -$2.66M -$6.08M -178% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-20
Q1 2019 -$281K -$215K -$1.3M -120% Jan 1, 2019 Mar 31, 2019 10-Q 2020-07-07
Q4 2018 $1.02M -$2.74M +$4.41M +61.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-20
Q3 2018 -$3.4M -$746K +$1.62M +68.5% Jul 1, 2018 Sep 30, 2018 10-Q 2020-03-09
Q2 2018 -$5.02M $3.42M +$4.49M Apr 1, 2018 Jun 30, 2018 10-Q 2020-02-11
Q1 2018 -$9.51M $1.08M +$1.19M Jan 1, 2018 Mar 31, 2018 10-Q 2019-07-11
Q4 2017 -$10.7M -$7.15M -$5.14M -256% Oct 1, 2017 Dec 31, 2017 10-K 2019-05-08
Q3 2017 -$5.55M -$2.37M -$2.15M -1021% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$3.4M -$1.07M +$808K +43% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$4.21M -$107K -$237K -182% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$3.97M -$2.01M -$250K -14.2% Oct 1, 2016 Dec 31, 2016 10-K/A 2018-04-20
Q3 2016 -$3.72M -$211K +$1.98M +90.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$5.7M -$1.88M -$173K -10.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-18
Q1 2016 -$5.53M $130K +$1.38M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-22
Q4 2015 -$6.9M -$1.76M +$1.44M +44.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-22
Q3 2015 -$8.34M -$2.19M +$781K +26.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-12-05
Q2 2015 -$9.12M -$1.71M +$446K +20.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-17
Q1 2015 -$9.57M -$1.25M +$317K +20.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-19
Q4 2014 -$9.88M -$3.2M -$985K -44.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$8.9M -$2.97M -$1.53M -107% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$7.36M -$2.15M -$402K -23% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$6.96M -$1.56M +$253K +13.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$7.22M -$2.21M -$1.03M -86.4% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-25
Q3 2013 -$6.19M -$1.44M -$452K -45.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$5.74M -$1.75M -$583K -50% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$5.16M -$1.82M -$802K -79.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$4.35M -$1.19M +$1.57M +57% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-26
Q3 2012 -$5.93M -$986K +$1.68M +62.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$7.6M -$1.17M -$671K -135% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$6.93M -$1.01M -$287K -39.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$6.64M -$2.76M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-27
Q3 2011 -$2.66M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$496K +$63K +11.3% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-24
Q1 2011 -$726K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q2 2010 -$559K Apr 1, 2010 Jun 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.